Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Mefloquine hydrochloride
Cat. No.:
OB0225LY-0281
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Mefloquine hydrochloride is a quinoline derivative with an anti-malarial effect.
Synonym:
Mefloquin hydrochloride; Mefloquine HCl; 51773-92-3; Mephaquin; (S)-[2,8-Bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol; hydrochloride; (R)-[2,8-Bis(trifluoromethyl)quinolin-4-yl](2S)-piperidin-2-ylmethanol hydrochloride
CAS No.:
51773-92-3
Compound CID:
65329
Formula:
C17H17ClF6N2
Formula Weight:
414.77
Specification
Relative Density:
1.383 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Mefloquine hydrochloride can be used for research on anti-malarial mechanisms or play an important role in drug development.
Library Information
Targets:
Reactive oxygen species; Potassium channel
Pathways:
Microbiology/Virology; Immunology/Inflammation; Membrane transporter/Ion channel; Autophagy; Metabolism; NF-κB
Plate Number:
AOCL-4
Plate Location:
e10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 120.55 mM
Ethanol Max Solubility:
76 mg/mL; 183.2 mM
